HRT and Breast Cancer
Association of Women for the Advancement of Research and Education Today is
 
ProjectAWARE logo


    You are here:  Home >  Managing Menopause >  HRT >  HRT and Breast Cancer Bookmark and Share

 

  Menopause Experience
  Menopause
Perimenopause
The 35 Symptoms
Premature Menopause
Postmenopause
Personal Stories
  Managing Menopause
  The Options
HRT
Alternatives to HRT
Exercise
Lifestyle
  Health Issues
  Breast Cancer
Heart Health
Osteoporosis
  Resources
  Article Archives
Books & Newsletters
Finding a Doctor
Glossary of Terms
Health Links
News Stories
Pharmacies
Studies & Trials
  Docs Corner
  Hormone Health
Wellness & You
Q & A
  about
  Who We Are
Kudos
  Advertising Statement
Privacy & Confidentiality
Link to Us
Support AWARE
Contact Us
  bottom
   

 

 

 

HRT and Breast Cancer

The WHI study added to the evidence that at least some types of HRT are associated with an increased risk of breast cancer. Other studies have found an increased risk of breast cancer in women who take estrogen for 5 or more years, the risk rising with longer duration of HRT use. Use of a progestin along with estrogen in these studies did not seem to reduce that rising risk and may even have increased it.

In the WHI study, the combination of the progestin medroxyprogesterone acetate (MPA) with estrogen in a daily pill appears to be responsible for the increased risk of breast cancer. The estrogen-only (Premarin) arm of the study is continuing and has not yet found an increased risk of breast cancer in the women taking unopposed estrogen. To read the latest information about the WHI studies on HRT, its risks, benefits and side effects, visit the National Heart, Lung and Blood Institute's web site.

There is evidence that micronized progesterone and progestins have differing effects on breast tissue, and that the regimen used plays a role. For example, taking both estrogen and the progestin medroxyprogesterone acetate (MPA) every day (continuous combined regimen) is known to cause increased breast density and is associated with an increased risk of breast cancer. Regimens that involve taking estrogen daily and progestin or progesterone for only part of each month (cyclical combined regimen) are less likely to cause increased breast density. Micronized progesterone used cyclically may actually help protect against breast cancer.

More research is needed about the varying effects of different formulations, doses, and regimens of HRT on the breast.

For more information and resources about breast cancer, please see this page at ProjectAWARE.

 

Please read on...

  What Is Hormone Replacement Therapy (HRT) and Why Would I Need It?
   What Hormones Are Used in HRT? and How Is HRT Taken?
  About Estrogen
  About Progesterone
  Benefits, Risks and Side Effects of ERT, HRT, and NHRT
  HRT and Breast Cancer
NEXT:
Androgens, SERMs and Other Drugs for Menopause
  What Are Some Alternatives to Standard HRT?
  Resources and References

 

Page uploaded September 2002

 

 

 

 
 
 

 

NOTE: When you click on a word in blue, a definition of the term will open in a new window.

Related
Adrenal Fatigue
Cortisol and Weight
DHEA or Testosterone for Women
Estrogen and Memory Loss
HRT for Breast Cancer Survivors and Women at High Risk for Cancer
Human Identical Hormones
Premarin, Facts and Opinions
Progesterone FAQ
Synthetic Progestins and Natural Progesterone, Differences
Natural Progesterone, What Role in Women's Healthcare
Tamoxifen for Prevention of Breast Cancer
Testosterone and Its Benefits to Women
Testosterone's Impact on Postmenopausal Women...
Thyroid Hormone, Symptoms, and...
Typical HRT Products
Where to get Natural Hormones
Herbal Allies, An Introduction
Alternative Remedies for Menopausal Symptoms

 

 

 

 

 

Copyright 1997-2010 ProjectAWARE. All rights reserved.

Questions or comments about this site? Contact the Website Editor, <aware.editor@project-aware.org>

Updated 09/29/2010